Third Peer-Reviewed Study Proves Botanical Formula Fights Prostate Cancer ... - MarketWatch (press release)

Third Peer-Reviewed Study Proves Botanical Formula Fights Prostate Cancer ... MarketWatch (press release) 8, 2012 /PRNewswire via COMTEX/ -- Scientists at Indiana University, Methodist Research Institute, study a botanical formula that kills aggressive prostate cancer tumors. Their findings, based on experiments in mice using a human prostate cancer tumor ... and more »

Benefit of Bone Drug in Prostate Cancer in Doubt - MedPage Today

USA TODAY

Benefit of Bone Drug in Prostate Cancer in Doubt MedPage Today Amgen would like to expand the indication to make the biologic available as a preventive treatment for men with castrate-resistant prostate cancer at high risk of developing bone metastases. The FDA's Oncologic Drugs Advisory Committee will meet ... FDA questions Amgen drug for prostate cancerUSA TODAY FDA doubts benefits of Amgen drug for prostate cancerGlobalPost all 222 news articles »